AcesoStem Biostrategies Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.68M
- Investors
-
7
AcesoStem Biostrategies General Information
Description
Developer of drugs and therapeutics designed to provide treatment for rotator cuff disease. The company's therapeutics are used in osteoarthritis treatment, musculoskeletal disorders, and other regenerative technologies, enabling healthcare professionals to provide patients suffering from Orthopedic conditions with effective treatment and help them recover.
Contact Information
Corporate Office
- 813, Boramae-ro 5ga-gil 7
- Gwanak-gu, Bongcheon-dong, Character Greenville
- Seoul, 08708
- South Korea
Corporate Office
- 813, Boramae-ro 5ga-gil 7
- Gwanak-gu, Bongcheon-dong, Character Greenville
- Seoul, 08708
- South Korea
AcesoStem Biostrategies Timeline
AcesoStem Biostrategies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 01-Jun-2026 | $2.68M | Completed | Clinical Trials - Phase 1 | ||
| 3. Accelerator/Incubator | 31-Oct-2023 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 12-Oct-2022 | $1.41M | $1.41M | Completed | Clinical Trials - General | |
| 1. Seed Round | 28-Oct-2021 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AcesoStem Biostrategies Signals
AcesoStem Biostrategies Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Premier Partners | PE/Buyout | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | |||
| Dream CIS | Corporation | Minority | ||
| Tap Angel Partners | Venture Capital | Minority | ||
| BlissVine Ventures | Venture Capital | Minority |
AcesoStem Biostrategies FAQs
-
When was AcesoStem Biostrategies founded?
AcesoStem Biostrategies was founded in 2019.
-
Where is AcesoStem Biostrategies headquartered?
AcesoStem Biostrategies is headquartered in Seoul, South Korea.
-
What is the size of AcesoStem Biostrategies?
AcesoStem Biostrategies has 13 total employees.
-
What industry is AcesoStem Biostrategies in?
AcesoStem Biostrategies’s primary industry is Drug Discovery.
-
Is AcesoStem Biostrategies a private or public company?
AcesoStem Biostrategies is a Private company.
-
What is AcesoStem Biostrategies’s current revenue?
The current revenue for AcesoStem Biostrategies is .
-
How much funding has AcesoStem Biostrategies raised over time?
AcesoStem Biostrategies has raised $4.1M.
-
Who are AcesoStem Biostrategies’s investors?
Premier Partners, Tech Incubator Program for Startup, Dream CIS, Tap Angel Partners, and BlissVine Ventures are 5 of 7 investors who have invested in AcesoStem Biostrategies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process